Fernández-García, P.; Rosselló, C.A.; Rodríguez-Lorca, R.; Beteta-Göbel, R.; Fernández-Díaz, J.; Lladó, V.; Busquets, X.; Escribá, P.V.
The Opposing Contribution of SMS1 and SMS2 to Glioma Progression and Their Value in the Therapeutic Response to 2OHOA. Cancers 2019, 11, 88.
https://doi.org/10.3390/cancers11010088
AMA Style
Fernández-García P, Rosselló CA, Rodríguez-Lorca R, Beteta-Göbel R, Fernández-Díaz J, Lladó V, Busquets X, Escribá PV.
The Opposing Contribution of SMS1 and SMS2 to Glioma Progression and Their Value in the Therapeutic Response to 2OHOA. Cancers. 2019; 11(1):88.
https://doi.org/10.3390/cancers11010088
Chicago/Turabian Style
Fernández-García, Paula, Catalina A. Rosselló, Raquel Rodríguez-Lorca, Roberto Beteta-Göbel, Javier Fernández-Díaz, Victoria Lladó, Xavier Busquets, and Pablo V. Escribá.
2019. "The Opposing Contribution of SMS1 and SMS2 to Glioma Progression and Their Value in the Therapeutic Response to 2OHOA" Cancers 11, no. 1: 88.
https://doi.org/10.3390/cancers11010088
APA Style
Fernández-García, P., Rosselló, C. A., Rodríguez-Lorca, R., Beteta-Göbel, R., Fernández-Díaz, J., Lladó, V., Busquets, X., & Escribá, P. V.
(2019). The Opposing Contribution of SMS1 and SMS2 to Glioma Progression and Their Value in the Therapeutic Response to 2OHOA. Cancers, 11(1), 88.
https://doi.org/10.3390/cancers11010088